Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 106351-106400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02812537
Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior
N/A
Recruiting
500 participants
Started: May 20, 2019 · Completed: May 31, 2028
1 condition
1 sponsor
1 location
NCT03808584
Impact of Core Muscle Training on Incisional Hernia and Pain After Abdominal Surgery
NA
Recruiting
588 participants
Started: May 20, 2019 · Completed: Dec 31, 2026
2 conditions
1 sponsor
5 locations
NCT07211646
The Assessment of Human Sleep and Its Functions
NA
Active, not recruiting
1,000 participants
Started: May 20, 2019 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT03875716
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
NA
Recruiting
111 participants
Started: May 20, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06315361
DIAbetes and NAFLD
N/A
Active, not recruiting
600 participants
Started: May 20, 2019 · Completed: Dec 31, 2035
6 conditions
1 sponsor
1 location
NCT03930953
A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)
PHASE1/PHASE2
Active, not recruiting
438 participants
Started: May 20, 2019 · Completed: Feb 9, 2028
1 condition
1 sponsor
66 locations
NCT05423704
Feasibility of Patient Selection and Treatment of Head-neck Cancer With Proton Therapy in Denmark
NA
Active, not recruiting
63 participants
Started: May 20, 2019 · Completed: May 14, 2026
1 condition
1 sponsor
7 locations
NCT03927261
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS
PHASE1
Active, not recruiting
88 participants
Started: May 20, 2019 · Completed: Aug 1, 2025
2 conditions
1 sponsor
2 locations
NCT03949829
The CoPenHagen PREeClampsia and cardIOvascUlar diSease Study
N/A
Active, not recruiting
921 participants
Started: May 20, 2019 · Completed: Jun 30, 2031
4 conditions
2 sponsors
3 locations
NCT03957135
Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled Trial
NA
Recruiting
244 participants
Started: May 20, 2019 · Completed: Nov 30, 2025
1 condition
7 sponsors
1 location
NCT03908736
Thinking Zinc: a Study of Zinc Supplements on the Navajo Nation
NA
Recruiting
100 participants
Started: May 19, 2019 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT06159270
Infectious Prospective Collection for Biological Analysis
N/A
Recruiting
22,870 participants
Started: May 18, 2019 · Completed: May 18, 2025
1 condition
1 sponsor
1 location
NCT03886961
The Effect of the Reflux Band™ Upper Esophageal Sphincter (UES) Assist Device on Reflux for Lung Transplant Recipients
NA
Recruiting
20 participants
Started: May 17, 2019 · Completed: Dec 20, 2027
2 conditions
2 sponsors
1 location
NCT03238794
Bariatric Surgery Versus Diet Alone in the Bile Acid Pathway and Weight Loss
NA
Active, not recruiting
21 participants
Started: May 17, 2019 · Completed: Jan 11, 2026
1 condition
2 sponsors
1 location
NCT05586997
Rapid Maxillary Expansion with Low Level Laser Therapy
PHASE3
Recruiting
60 participants
Started: May 17, 2019 · Completed: Mar 30, 2026
4 conditions
2 sponsors
1 location
NCT04019197
Effects of Semaglutide in HIV-Associated Lipohypertrophy
PHASE2
Active, not recruiting
108 participants
Started: May 16, 2019 · Completed: Mar 31, 2025
3 conditions
3 sponsors
2 locations
NCT03890614
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
N/A
Recruiting
70 participants
Started: May 16, 2019 · Completed: Feb 28, 2026
1 condition
2 sponsors
1 location
NCT03784313
Perforator Flaps for Axillary Hidradenitis Suppurativa
NA
Active, not recruiting
88 participants
Started: May 16, 2019 · Completed: Sep 24, 2024
1 condition
1 sponsor
1 location
NCT03745326
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
PHASE1/PHASE2
Recruiting
70 participants
Started: May 16, 2019 · Completed: Dec 1, 2028
5 conditions
1 sponsor
1 location
NCT03956095
Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer
N/A
Active, not recruiting
23 participants
Started: May 16, 2019 · Completed: May 31, 2026
1 condition
1 sponsor
8 locations
NCT03852381
Mechanisms and Outcome-Prognostication for Paresthesia-based and -free Spinal Cord Stimulation
NA
Recruiting
90 participants
Started: May 16, 2019 · Completed: Dec 31, 2025
2 conditions
2 sponsors
1 location
NCT03655665
Does Topical Otic Drop Use at Time of Tympanostomy Tube Surgery Improve Outcomes When no Middle Ear Effusion is Present
PHASE4
Recruiting
125 participants
Started: May 16, 2019 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT03951831
REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer
PHASE2
Active, not recruiting
26 participants
Started: May 16, 2019 · Completed: Apr 30, 2028
1 condition
2 sponsors
1 location
NCT03830151
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
PHASE1
Recruiting
13 participants
Started: May 16, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03812172
Screening for Cardiac Amyloidosis with Nuclear Imaging for Minority Populations
N/A
Active, not recruiting
650 participants
Started: May 15, 2019 · Completed: Apr 30, 2025
1 condition
6 sponsors
4 locations
NCT03820817
Rifaximin in Patients With Monoclonal Gammopathy
PHASE1
Active, not recruiting
50 participants
Started: May 15, 2019 · Completed: Nov 30, 2025
9 conditions
2 sponsors
1 location
NCT03886311
Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
PHASE2
Recruiting
200 participants
Started: May 15, 2019 · Completed: Jul 31, 2031
1 condition
1 sponsor
1 location
NCT03969706
Abemaciclib in Patients with Oligodendroglioma
PHASE2
Active, not recruiting
10 participants
Started: May 15, 2019 · Completed: May 15, 2027
1 condition
3 sponsors
1 location
NCT03980002
A Prospective Multicenter Phase 2 Study of FCR/BR Alternating With Ibrutinib in Treatment-naive Patients With CLL
PHASE2
Recruiting
50 participants
Started: May 15, 2019 · Completed: Dec 30, 2027
1 condition
1 sponsor
1 location
NCT04136132
Prospective Monocentric Clinical-biological Database
NA
Recruiting
120 participants
Started: May 15, 2019 · Completed: Jun 30, 2034
1 condition
1 sponsor
1 location
NCT03938649
SRAM Study_Postate Cancer
PHASE2
Active, not recruiting
120 participants
Started: May 15, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04287647
Transpyloric Stenting As a Predictor for G-POEM for Refractory Gastroparesis
NA
Recruiting
36 participants
Started: May 15, 2019 · Completed: Jun 6, 2026
1 condition
1 sponsor
1 location
NCT03991416
Understanding Your Baby: A Parallel Group Study of a Universal Parenting Support Program
NA
Active, not recruiting
1,737 participants
Started: May 15, 2019 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03971461
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
PHASE2
Active, not recruiting
32 participants
Started: May 15, 2019 · Completed: Jan 31, 2027
1 condition
1 sponsor
2 locations
NCT03835403
The HeartRunner Trial
NA
Recruiting
1,600 participants
Started: May 15, 2019 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT04028219
Transgender In Transition
N/A
Recruiting
750 participants
Started: May 15, 2019 · Completed: May 15, 2034
1 condition
1 sponsor
5 locations
NCT04045431
Treatment of Knee Osteoarthritis With PAAG-OA
NA
Active, not recruiting
238 participants
Started: May 15, 2019 · Completed: Nov 30, 2026
1 condition
1 sponsor
3 locations
NCT05629104
Prediction of Long-term Outcome in Aortic Stenosis After Valve Intervention
N/A
Recruiting
300 participants
Started: May 15, 2019 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT03872752
Development and Implementation of Food Literacy Workshops in the Community
NA
Recruiting
150 participants
Started: May 15, 2019 · Completed: Dec 1, 2026
3 conditions
1 sponsor
1 location
NCT05189769
Reducing Racism and Discrimination in Schools: Comprehensive Prevention Services
NA
Active, not recruiting
1,093 participants
Started: May 15, 2019 · Completed: Dec 1, 2025
1 condition
1 sponsor
2 locations
NCT03838159
NADIM II: Neo-Adjuvant Immunotherapy
PHASE2
Active, not recruiting
90 participants
Started: May 15, 2019 · Completed: Nov 30, 2028
1 condition
1 sponsor
25 locations
NCT03929900
KNOW-CKD Cohort, Phase II Study
N/A
Recruiting
1,500 participants
Started: May 15, 2019 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03939481
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
N/A
Active, not recruiting
1,336 participants
Started: May 14, 2019 · Completed: Feb 28, 2026
46 conditions
2 sponsors
169 locations
NCT03917381
GEN1046 Safety Trial in Patients With Malignant Solid Tumors
PHASE1/PHASE2
Active, not recruiting
429 participants
Started: May 14, 2019 · Completed: Feb 28, 2026
7 conditions
1 sponsor
57 locations
NCT05913518
Neurofeedback Training of Metacognition in Subjects With Alcohol Use Disorder. Disorder Induces Neural Modifications: an Event-related Potentials Study
NA
Recruiting
130 participants
Started: May 14, 2019 · Completed: Jun 1, 2025
1 condition
1 sponsor
1 location
NCT03965429
Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation
N/A
Active, not recruiting
1,020 participants
Started: May 14, 2019 · Completed: May 31, 2029
1 condition
2 sponsors
1 location
NCT03896269
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
PHASE1
Recruiting
38 participants
Started: May 14, 2019 · Completed: Dec 31, 2027
7 conditions
2 sponsors
1 location
NCT03686124
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1/PHASE2
Recruiting
375 participants
Started: May 14, 2019 · Completed: Jun 30, 2032
4 conditions
1 sponsor
15 locations
NCT03870672
rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke
NA
Recruiting
72 participants
Started: May 14, 2019 · Completed: Apr 30, 2026
4 conditions
2 sponsors
1 location
NCT03913559
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
PHASE2
Recruiting
32 participants
Started: May 14, 2019 · Completed: Dec 31, 2031
1 condition
2 sponsors
2 locations
Previous
1
More pages
2125
2126
2127
2128
2129
2130
2131
More pages
2369
Next